Stefanie Dimmeler has been awarded the Otto Warburg Medal 2022. The Society for Biochemistry and Molecular Biology (GBM) as well as its cooperation partners, the information analytics company Elsevier and Biochimica et Biophysica Acta (BBA) journals, honoured Prof. Dimmeler her pioneering work in the field of cardiovascular disease
With her findings, Prof. Dimmeler has been able to make a fundamental contribution to the understanding of cardiovascular diseases and develop therapeutic approaches aimed at improving cardiovascular regeneration after a heart attack.
Cardiovascular diseases are among the leading causes of death worldwide. Prof. Dimmeler and her team have succeeded in using an inhibitor against a non-coding RNA to improve blood flow and strengthen cardiac function. The goal of their various approaches is to develop new cellular and pharmacological therapies to improve the treatment of cardiovascular diseases.
You need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from Turnstile to submit the form. Please note that doing so will share data with third-party providers.
More Information
